Claudia Arce - Concepedia

Author

Claudia Arce

Instituto Nacional de Cancerología ORCID

Also Known As

C Arce, C Slocker De Arce, C. Arce, Claudia Arce, Claudia S Arce, Universidad de San Buenaventura de Cartagena

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Cancerología Universidad Nacional Autónoma de México Universidad de Cuautitlán Izcalli

About

Claudia Arce is an author at Instituto Nacional de Cancerología specializing in radiation oncology, oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	279
2	Pharmacology	1	1	249
3	Surgical Oncology	1	1	30
4	Cancer Therapeutics	1	1	249
5	Breast Cancer	1	1	30

Claudia Arce

Publications

830

Citations

H-Index

Page 1

	Year	Citations
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors Myrna Candelaria, Dolores Gallardo‐Rincón, Claudia Arce, Annals of Oncology Chemotherapy ResistanceMedicinePharmacologyMagnesium ValproatePharmacotherapy	2007	249
Triple‐negative breast cancer in Hispanic patients Fernando Lara-Medina, Víctor M. Pérez-Sánchez, David Saavedra-Pérez, Cancer	2011	214
A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer Claudia Arce, Carlos Pérez‐Plasencia, Aurora González‐Fierro, PLoS ONE	2006	144
Hydralazine target: From blood vessels to the epigenome Claudia Arce, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas, Journal of Translational Medicine	2006	117
Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature Claudia Arce, David Eleazar Cortés-Padilla, DG Huntsman, World Journal of Surgical Oncology	2005	65
Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients Diana Flores-Díaz, Claudia Arce, Lourdes Flores‐Luna, Breast Cancer Research and Treatment Surgical OncologyBreast OncologyInvasive Lobular CarcinomaMedicineCancer Management	2019	30
A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer Claudia Arce, Carlos Pérez‐Plasencia, Aurora González‐Fierro, BMC Cancer	2007	11

Page 1